Get the Stockscreener App
29.23
4.79%
-1.47
After Hours:
29.11
-0.12
-0.41%
Schrodinger Inc stock is traded at $29.23, with a volume of 3.06M.
It is down -4.79% in the last 24 hours and up +48.30% over the past month.
Schrodinger Inc is a healthcare-based software company. It offers software solutions designed to support and accelerate the discovery, design, and optimization of molecules. The company operates in two reportable segments: Software and Drug Discovery. The software segment is focused on selling software to transform drug discovery across the life sciences industry, as well as to customers in materials science industries. The drug discovery segment is focused on generating revenue from a diverse portfolio of preclinical and clinical programs, internally and through collaborations, that have various stages of discovery and development. The majority of the company's revenue is derived from the Software segment. Geographically, it derives the maximum revenue from the United States.
See More
Previous Close:
$30.70
Open:
$30.05
24h Volume:
3.06M
Relative Volume:
2.08
Market Cap:
$2.19B
Revenue:
$254.91M
Net Income/Loss:
$-103.48M
P/E Ratio:
-20.83
EPS:
-1.4036
Net Cash Flow:
$-148.35M
1W Performance:
+22.15%
1M Performance:
+48.30%
6M Performance:
+146.25%
1Y Performance:
+53.36%
1-Day Range:
$28.32
$31.14
1-Week Range:
$24.09
$31.59
52-Week Range:
$10.95
$31.59
Schrodinger Inc Stock (SDGR) Company Profile
Name
Schrodinger Inc
Sector
Industry
Phone
503-299-1150
Address
1540 BROADWAY, NEW YORK, NY
Compare SDGR vs VEEV, TEM, BTSG, TXG, HQY
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SDGR
Schrodinger Inc
|
29.23 | 2.30B | 254.91M | -103.48M | -148.35M | -1.4036 |
VEEV
Veeva Systems Inc
|
270.75 | 42.24B | 3.32B | 941.65M | 1.64B | 5.6161 |
TEM
Tempus Ai Inc
|
76.59 | 14.01B | 1.36B | -302.91M | -219.93M | -1.7182 |
BTSG
Brightspring Health Services Inc
|
55.78 | 11.19B | 13.65B | 169.86M | 412.12M | 1.0758 |
TXG
10 X Genomics Inc
|
75.62 | 10.51B | 638.78M | -22.66M | 122.18M | -0.1744 |
HQY
Healthequity Inc
|
90.39 | 7.59B | 1.34B | 230.70M | 440.96M | 2.6695 |
Schrodinger Inc Stock (SDGR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-15-25 | Upgrade | BofA Securities | Neutral → Buy |
| Sep-30-25 | Initiated | Goldman | Neutral |
| Aug-15-25 | Downgrade | Citigroup | Buy → Neutral |
| Aug-14-25 | Initiated | Barclays | Overweight |
| Jul-03-25 | Resumed | Morgan Stanley | Equal-Weight |
| Jul-02-24 | Initiated | Leerink Partners | Outperform |
| Dec-05-23 | Initiated | KeyBanc Capital Markets | Overweight |
| May-05-23 | Resumed | Piper Sandler | Overweight |
| Dec-19-22 | Initiated | Goldman | Neutral |
| Mar-01-22 | Initiated | Citigroup | Buy |
| Nov-19-21 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Nov-19-21 | Initiated | Piper Sandler | Overweight |
| Nov-11-21 | Downgrade | BofA Securities | Buy → Neutral |
| Oct-13-21 | Initiated | Berenberg | Buy |
| Sep-01-21 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| May-25-21 | Initiated | Craig Hallum | Buy |
| Nov-23-20 | Upgrade | BofA Securities | Neutral → Buy |
| Oct-12-20 | Upgrade | Jefferies | Hold → Buy |
| Mar-02-20 | Initiated | BMO Capital Markets | Outperform |
| Mar-02-20 | Initiated | Jefferies | Hold |
| Mar-02-20 | Initiated | Morgan Stanley | Equal-Weight |
View All
Schrodinger Inc Stock (SDGR) Latest News
Schrödinger Drops 7.6% Amid Sector-Wide Selling - AlphaStreet
Schrodinger Stock Has Technical Strength as It Hits New 2-Year Highs - Barchart.com
Precision Trading with Schrodinger Inc. (SDGR) Risk Zones - Stock Traders Daily
Biosimulation Market Set for Strong Growth Through 2035, Fueled by AI-Driven Drug Discovery, Virtual Trials and Precision Medicine Demand - GlobeNewswire Inc.
Schrodinger stock gains 69.1 percent year to date - AD HOC NEWS
Schrodinger president Karen Akinsanya sells $927,970 in company stock By Investing.com - Investing.com South Africa
Options at $4.34 become shares sold near $30 for Schrodinger (SDGR) insider - Stock Titan
SDGR Q2 2026 Earnings: EPS Swings to Profit, Beating Estimates by 116%Estimate Revision Count - careplusvn.com
Schrödinger, Inc. Partners with NEA and RA Capital Management to Co-Found Tectora - Labroots
Schrodinger Inc. (SDGR) Stock Price | Live Quotes & Charts | NASDAQ - timothysykes.com
Schrodinger Inc (SDGR) Shares Fall 4.0% -- GF Value Says Still O - GuruFocus
Schrodinger Stock Price Forecast. Should You Buy SDGR? - StockInvest.us
Schrödinger options flow points to bullish positioning ahead of potential catalyst - Investing.com
Schrodinger Inc (SDGR) Stock Up 26.4% but GF Value Says Overvalued -- GF Score: 73/100 - GuruFocus
Schrödinger (SDGR) Stock Surges 60% but $37 Resistance Could Test the Rally as Mixed Fundamentals Raise Fresh Risks - FXLeaders
Insider at Schrodinger (NASDAQ: SDGR) plans September 2026 stock sale - Stock Titan
Schrödinger (SDGR) Surges 13.5% to $27.15 - AlphaStreet
$Schrodinger (SDGR.US)$ what happened?[Blush] - Moomoo
Schrödinger: Company Creation Is Now The Real Drug Business (NASDAQ:SDGR) - Seeking Alpha
SDGR Looks 3.2% Undervalued on GF Value™ - GuruFocus
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - Yahoo Finance
Schrödinger (SDGR) Rallies On Tectora Deal But Is The Upside Already Priced In - simplywall.st
Schrodinger (SDGR) Soars 12.1%: Is Further Upside Left in the Stock? - Yahoo Finance
SDGR Looks 5.9% Undervalued on GF Value™ as AI-Driven Surge Lifts Shares - GuruFocus
Schrödinger jumps 12% to new 52-week high amid AI drug-discovery interest (SDGR:NASDAQ) - Seeking Alpha
Schrodinger Inc stock hits 52-week high at 23.06 USD By Investing.com - Investing.com Australia
Schrodinger Inc stock hits 52-week high at 23.06 USD - Investing.com
SDGR: AI-driven platform innovation and hosted solutions fuel growth, with profitability targeted by 2028 - TradingView
Understanding the Setup: (SDGR) and Scalable Risk - Stock Traders Daily
Schrödinger introduces Tectora Therapeutics - BioWorld News
Tectora Therapeutics inc. announced that it has received $55 million in funding from New Enterprise Associates, Inc., RA Capital Management, L.P., Schrödinger, Inc. - marketscreener.com
Schrödinger Announces Licensing and Collaboration Agreement with Tectora Therapeutics, a New Biotechnology Company It Co-founded to Advance Immunology and Inflammation Programs - BioSpace
SDGR Looks 19.2% Undervalued on GF Value™ - GuruFocus
Schrodinger Establishes Tectora Therapeutics With RA Capital, New Enterprise Associates - marketscreener.com
A new drug company raises $55 million for oral medicines - Stock Titan
Is Schrodinger Inc (SDGR) a Bargain After 3.1% Drop? GF Value Sa - GuruFocus
Schrodinger (SDGR) Slips 1.3% as Shares Hold Above Key $19.58 SupportPut Flow Alert - dars.gov.et
Can RXRX's Pipeline Expansion Strengthen Its Long-Term Growth Outlook? - TradingView
“Schrodinger’s Strait:” Why Hormuz Now Exists in a State of Permanent Uncertainty - Yahoo Finance
AI in Drug Discovery Market Projected to Reach $8.52 Billion By 2030 - PR Newswire
Schrödinger’s Strait - الحرة
Price-Driven Insight from (SDGR) for Rule-Based Strategy - Stock Traders Daily
Drug Discovery Platforms Market to Reach USD 16.5 Billion by 2036, Driven by AI-Powered Research and Rising Pharmaceutical R&D Investment - industrytoday.co.uk
Schrödinger to Present at Morgan Stanley Global Healthcare Conference 2026 - BioSpace
Schrödinger to Present at Morgan Stanley Global Healthcare Conference - Yahoo Finance
Schrodinger Inc. (SDGR) Slips 1.81% to $20.04 as Stock Holds Above Key SupportInsider Selling Alerts - dars.gov.et
Schrodinger (SDGR) Results Review: Profit Per Share Surpasses Its Benchmark; Investor Response: The Stock Ends Up 6.50% for the Current SessionNew Analyst Coverage - careplusvn.com
SDGR | Schrodinger, Inc. Common Stock FinancialsRevenue Breakdown - Quiver Quantitative
Tectora Therapeutics, Inc. announced that it expects to receive $55 million in funding - marketscreener.com
Schrödinger: The Software Business Is Stronger Than It Looks (NASDAQ:SDGR) - Seeking Alpha
Schrödinger (SDGR) Q2 2026 Earnings Call Transcript - AOL.com
Schrodinger Inc Stock (SDGR) Financials Data
Revenue
Net Income
Cash Flow
EPS
Schrodinger Inc Stock (SDGR) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Akinsanya Karen | See Remarks |
Sep 17 '26 |
Sale |
29.37 |
31,599 |
927,970 |
69,956 |
0.21%
0.23%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):